Formulation and Particle Size Reduction Improve Bioavailability of Poorly Water-Soluble Compounds with Antimalarial Activity

Figure 5

Concentration versus time profiles of WR299666 in plasma following single oral dose of suspensions in made by glass grinder (42.22 µm) and ultrasonicator (1.50 µm). The same drug preparations were used as shown in Figure 3.